Pluri (PLUR) Appoints Lorne Abony to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors
July 13, 2023 2:01 AM EDTHAIFA, Israel, July 13, 2023 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (Pluri or the Company), a leading biotech company that transforms cells into solutions that promote wellbeing and sustainability, today announced the appointment of Lorne Abony to the Companys Board of Directors, effective as of July 11, 2023.Â
Abony is a successful entrepreneur who has decades of experience building and scaling multi-billion-dollar global businesses both public and private companies across multiple industries. He is a globally recognized leader who has invested, directly or indirectly, in more than 20 cellular... More
